These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13800475)

  • 1. [First clinical trials of a new synthetic antidiabetic SB 1 or 1-(3-aminobenzenesulfonyl)-3-n-butylurea].
    BICKEL G; KORALNIK O
    Schweiz Med Wochenschr; 1959 Nov; 89():1186-91. PubMed ID: 13800475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on the absence of antibacterial properties in a new synthetic antidiabetic, 1-(3-aminobenzenesulfonyl)-3-n-butylurea or SB 1].
    REGAMEY RH
    Schweiz Med Wochenschr; 1959 Nov; 89():1183-6. PubMed ID: 14436950
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental studies on the mechanism of the therapeutic effect of antidiabetic sulfonyl-urea].
    OHONO T
    Nihon Naibunpi Gakkai Zasshi; 1961 Nov; 37():869-95. PubMed ID: 14481417
    [No Abstract]   [Full Text] [Related]  

  • 4. [The therapy of diabetes mellitus with SB 1].
    BERINGER A
    Wien Med Wochenschr; 1960 Feb; 110():109-11. PubMed ID: 13799474
    [No Abstract]   [Full Text] [Related]  

  • 5. [Findings in the course of antidiabetic treatment with 1-para-aminobenzenesulfonyl-3-N-butyl urea].
    MORSIANI M; SERRAVALLI S
    Arcisp S Anna Ferrara; 1956; 9(4):747-59. PubMed ID: 13382613
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new oral antidiabetic: N,N-dimethylbiguanide. Therapeutic trials alternated with a placebo and a sulfonamide].
    PIRART J; RUTMAN S
    Acta Clin Belg; 1961; 16():575-89. PubMed ID: 14486867
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trials of a new antidiabetic sulfonamide: phenbutamide].
    DORCHE J; TRAEGER J; MALLEIN R; JARLOT C; TOCHON C
    Lyon Med; 1960 Mar; 92():789-808. PubMed ID: 13817640
    [No Abstract]   [Full Text] [Related]  

  • 8. [Our experience with the therapeutic use of a new sulfanylurea: N-propyl-N-(p-chlorobenzensulfonyl) urea-P607-by oral route in diabetes mellitus].
    SIGNORELLI S; POLOSA P
    Minerva Med; 1959 Aug; 50():2535-42. PubMed ID: 14446587
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory and clinical observations with a new sulfonylurea.
    SILVER AA; WISHINSKY H; CAPLAN RF; MONK C
    Ann N Y Acad Sci; 1959 Sep; 82():624-31. PubMed ID: 14446734
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antidiabetic sulfonamides with a chemical structure inducing delayed action. 3. Clinical trials with phenbutamide].
    TRAEGER J; FREYCON MT; MICHAUD P
    Therapie; 1959; 14():876-84. PubMed ID: 13839137
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the treatment of diabetes with a new oral antidiabetic. Clinical contribution].
    BRIGUGLIO FS; ASMUNDO G
    Minerva Med; 1959 Aug; 50():2583-6. PubMed ID: 13804430
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypoglycaemic activity of N-benzenesulphonyl-N'-iso-propylurea and N-benzenesulphonyl-N'-n-butylurea in experimental animals.
    TONSE U; ANANTHANARAYANAN KG; MHASALKAR MY; SHAH MH; DELIWALA CV
    Nature; 1962 Mar; 193():891. PubMed ID: 13921881
    [No Abstract]   [Full Text] [Related]  

  • 13. An assessment of oral antidiabetic therapy.
    DOLGER H
    J Mt Sinai Hosp N Y; 1960; 27():33-9. PubMed ID: 13817306
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the antidiabetic action of chlorpropamide (P-607). Clinical experience].
    BOARI L
    Boll Soc Med Chir Cremona; 1960; 14():97-114. PubMed ID: 13801771
    [No Abstract]   [Full Text] [Related]  

  • 15. [Application of oral antidiabetic drugs].
    KALDOR A
    Orv Hetil; 1959 Oct; 100():1502-6. PubMed ID: 13853208
    [No Abstract]   [Full Text] [Related]  

  • 16. An assessment of oral antidiabetic therapy.
    DOLGER H
    Ann N Y Acad Sci; 1959 Sep; 82():531-6. PubMed ID: 13817305
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral antidiabetic therapy.
    WILLIAMS RH; POLLEN RH; TANNER DC; BARNES RH
    Ann Intern Med; 1959 Dec; 51():1121-33. PubMed ID: 13844930
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dependency of serum concentration and blood sugar effect of N-4-methylbenzene-sulfonyl-N-butylurea (rastinon, D 860, artosin) on dosage in prolonged intravenous infusions].
    HASSELBLATT A; BLUDAU W
    Klin Wochenschr; 1958 Feb; 36(4):157-63. PubMed ID: 13540141
    [No Abstract]   [Full Text] [Related]  

  • 19. [Synthetic oral antidiabetics].
    ACHELIS JD
    Rev Iber Endocrinol; 1960; 7():173-90. PubMed ID: 13791625
    [No Abstract]   [Full Text] [Related]  

  • 20. [Peroral antidiabetic Tobucin-SPOFA in the treatment of juvenile verruca plana].
    KUTA A
    Cesk Dermatol; 1961 Sep; 36():396-400. PubMed ID: 14460932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.